Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04323449 · ClinicalTrials.gov registry record · NA

Evaluation of Vision-Guided Shared Control for Assistive Robotics Manipulators

A NA study of Spinal Cord Injury/Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT04323449: Completed NA study of Spinal Cord Injury/Disorder, sponsored by VA Office of Research and Development.

NCT04323449 is a NA study of Spinal Cord Injury/Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04323449, a NA study of Spinal Cord Injury/Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate a new control (i.e., the vision-guided shared (VGS) control) for a wheelchair-mounted assistive robotic manipulator among powered wheelchair users. This study consists of a questionnaire about general demographics, health information, and previous experience with assistive technology. Several tests are also administered to test upper extremity function and ability as well as to test spatial orientation and visualization ability. Participants till then undergo a training phase with the assistive robotic manipulator mounted on a table to assess if they are eligible for participation in the study. Eligible participants will move on to a second training phase where they are asked to learn and practice slightly more complex tasks while using the vision-guided shared controller. After this training, participants are asked to complete two everyday tasks each comprising multiple steps using the VGS control and default teleoperation using a joystick. At the conclusion of the study, researchers conduct a brief semi-structured interview with each participant and obtain more insight on how participants perceive the ease-of-use and usefulness of the vision-guided shared control.

Primary Outcome

Each task consisted of multiple predefined steps (six for the Drinking Task and ten for the Popcorn Task). Participants performed two trials per task. The time of completion was defined as the total time (in seconds) required to complete all steps, measured from the start cue to task completion. Each step had a 5-minute limit; if not completed within that time, the step was considered failed and assigned the maximum 5-minute duration before proceeding to the next step. Task completion times were

Interventions

  • DEVICE Compare two control methods for a wheelchair-mounted robotic manipulator

Study Locations (1)

Pennsylvania

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2022-04-13
Est. Completion 2024-06-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT04323449 record still lists

NCT04323449 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Spinal Cord Injury/Disorder appearing as the primary indexed condition, and to 1 intervention - of which Compare two control methods for a wheelchair-mounted robotic manipulator is the first listed.

NCT04323449 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04323449 about?

NCT04323449 is a clinical study titled "Evaluation of Vision-Guided Shared Control for Assistive Robotics Manipulators". The purpose of this study is to evaluate a new control (i.e., the vision-guided shared (VGS) control) for a wheelchair-mounted assistive robotic manipulator among powered wheelchair users. This study consists of a questionnaire about general demographics, health information, and previous experience ...

What is the current status of trial NCT04323449?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-04-13. Estimated completion is 2024-06-30.

What conditions does trial NCT04323449 study?

This clinical trial studies the following conditions: Spinal Cord Injury/Disorder.

What interventions are being tested in trial NCT04323449?

The interventions under investigation include: Compare two control methods for a wheelchair-mounted robotic manipulator (DEVICE).

Who is sponsoring clinical trial NCT04323449?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04323449 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04323449's enrollment target sits among peer trials

21 1762nd of 2000 higher than 233 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04323449, the US trial registry maintained by the National Library of Medicine. NCT04323449 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.